Symbols / MACI Stock $10.81 -0.05% Melar Acquisition Corp. I
MACI (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Melar Acquisition Corp. I does not have significant operations. It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. Melar Acquisition Corp. was incorporated in 2024 and is based in New York, New York.
Ratings
- Short Interest in Melar Acquisition Corp. I (NASDAQ:MACI) Drops By 18.3% - MarketBeat Fri, 01 May 2026 00
- MACI Price Today: Melar Acquisition Corp. I Stock Price, Quote & Chart | MEXC - MEXC Exchange Sun, 26 Apr 2026 16
- FDA MACI Approval Tests Vericel’s Capacity Plans And Growth Story - Yahoo Finance ue, 10 Mar 2026 07
- FDA approves new Vericel cell therapy plant to expand cartilage repair - Stock Titan Wed, 04 Mar 2026 08
- Vericel Corporation Anticipates $276 Million Total Revenue and 23% Growth in Fourth Quarter Results - Quiver Quantitative ue, 13 Jan 2026 08
- Debt-Free Balance Sheet, MACI Momentum, And Burn Care Portfolio Put Vericel On Investors' Radar - RTTNews Wed, 14 Jan 2026 08
- Melar Acquisition Corp. I (NASDAQ:MACI) Short Interest Update - MarketBeat ue, 14 Apr 2026 07
- MACI Stock Analysis: Melar Acquisition Corp. I Flat at 10.77 Performance Outlook - Xã Vĩnh Công Fri, 03 Apr 2026 07
- Is Rani (RANI) Stock a Good Buy in 2026 | Price at $0.82, Up 0.86% - Collaborative Trading Signals - Cổng thông tin điện tử Tỉnh Sơn La Wed, 08 Apr 2026 07
- Melar Acquisition Enhances Financing for Everli Merger Transaction - TipRanks hu, 02 Apr 2026 07
- symbol__ Stock Quote Price and Forecast - CNN hu, 20 Jun 2024 22
- Is Culp (CULP) Stock defensive in downturns | Price at $2.71, Down 0.37% - Investment Community Signals - UBND thành phố Hải Phòng hu, 02 Apr 2026 07
- MACI Stock Price and Chart — NASDAQ:MACI - TradingView Wed, 17 Jul 2024 21
- MACI Forecast — Price Prediction for 2026. Should I Buy MACI? - Intellectia AI ue, 13 May 2025 06
- Vericel's SWOT analysis: MACI arthro approval boosts cartilage repair stock - Investing.com ue, 17 Dec 2024 08
Insider Transactions
No recent insider transactions.
Financials
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Total Revenue |
|
0.00
|
| Operating Revenue |
|
0.00
|
| Operating Expense |
|
1.48
|
| Selling General And Administration |
|
1.48
|
| General And Administrative Expense |
|
1.48
|
| Other Gand A |
|
1.48
|
| Total Expenses |
|
1.48
|
| Operating Income |
|
-1.48
|
| Total Operating Income As Reported |
|
-1.48
|
| EBITDA |
|
6.08
|
| Normalized EBITDA |
|
-0.92
|
| EBIT |
|
6.08
|
| Total Unusual Items |
|
7.00
|
| Total Unusual Items Excluding Goodwill |
|
7.00
|
| Net Income |
|
5.54
|
| Pretax Income |
|
5.54
|
| Net Non Operating Interest Income Expense |
|
0.02
|
| Interest Expense Non Operating |
|
0.54
|
| Net Interest Income |
|
0.02
|
| Interest Expense |
|
0.54
|
| Interest Income Non Operating |
|
0.56
|
| Interest Income |
|
0.56
|
| Other Income Expense |
|
7.00
|
| Gain On Sale Of Security |
|
7.00
|
| Tax Rate For Calcs |
|
0.00
|
| Tax Effect Of Unusual Items |
|
1.47
|
| Net Income Including Noncontrolling Interests |
|
5.54
|
| Net Income From Continuing Operation Net Minority Interest |
|
5.54
|
| Net Income From Continuing And Discontinued Operation |
|
5.54
|
| Net Income Continuous Operations |
|
5.54
|
| Normalized Income |
|
0.01
|
| Net Income Common Stockholders |
|
5.54
|
| Diluted EPS |
|
0.26
|
| Basic EPS |
|
0.26
|
| Basic Average Shares |
|
21.62
|
| Diluted Average Shares |
|
21.62
|
| Diluted NI Availto Com Stockholders |
|
5.54
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 |
|---|---|---|---|
| Total Assets |
|
175.31
+5.92%
|
165.52
|
| Current Assets |
|
3.91
+274.50%
|
1.04
|
| Cash Cash Equivalents And Short Term Investments |
|
0.03
-96.35%
|
0.88
|
| Cash And Cash Equivalents |
|
0.03
-96.35%
|
0.88
|
| Cash Financial |
|
0.03
-96.35%
|
0.88
|
| Receivables |
|
3.81
|
0.00
|
| Prepaid Assets |
|
0.07
-57.19%
|
0.17
|
| Total Non Current Assets |
|
171.41
+4.21%
|
164.48
|
| Non Current Prepaid Assets |
|
0.00
-100.00%
|
0.07
|
| Other Non Current Assets |
|
171.41
+4.26%
|
164.41
|
| Total Liabilities Net Minority Interest |
|
10.89
+64.05%
|
6.64
|
| Current Liabilities |
|
4.29
+10311.55%
|
0.04
|
| Payables And Accrued Expenses |
|
0.58
+1298.63%
|
0.04
|
| Current Debt And Capital Lease Obligation |
|
3.72
|
—
|
| Current Debt |
|
3.72
|
—
|
| Other Current Borrowings |
|
3.72
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
6.60
+0.00%
|
6.60
|
| Non Current Deferred Liabilities |
|
6.60
+0.00%
|
6.60
|
| Stockholders Equity |
|
164.42
+3.49%
|
158.88
|
| Common Stock Equity |
|
164.42
+3.49%
|
158.88
|
| Capital Stock |
|
171.41
+4.26%
|
164.41
|
| Common Stock |
|
171.41
+4.26%
|
164.41
|
| Preferred Stock |
|
0.00
|
0.00
|
| Share Issued |
|
21.62
+0.00%
|
21.62
|
| Ordinary Shares Number |
|
21.62
+0.00%
|
21.62
|
| Additional Paid In Capital |
|
0.00
|
0.00
|
| Retained Earnings |
|
-6.99
-26.41%
|
-5.53
|
| Total Equity Gross Minority Interest |
|
164.42
+3.49%
|
158.88
|
| Total Capitalization |
|
164.42
+3.49%
|
158.88
|
| Working Capital |
|
-0.39
-138.52%
|
1.00
|
| Invested Capital |
|
168.14
+5.83%
|
158.88
|
| Total Debt |
|
3.72
|
—
|
| Net Debt |
|
3.69
|
—
|
| Net Tangible Assets |
|
164.42
+3.49%
|
158.88
|
| Tangible Book Value |
|
164.42
+3.49%
|
158.88
|
| Duefrom Related Parties Current |
|
3.81
|
0.00
|
| Line Item | Trend | 2025-12-31 |
|---|---|---|
| Operating Cash Flow |
|
-0.77
|
| Cash Flow From Continuing Operating Activities |
|
-0.77
|
| Net Income From Continuing Operations |
|
5.54
|
| Other Non Cash Items |
|
-7.01
|
| Change In Working Capital |
|
0.70
|
| Change In Receivables |
|
0.00
|
| Change In Prepaid Assets |
|
0.17
|
| Change In Payables And Accrued Expense |
|
0.54
|
| Investing Cash Flow |
|
-3.25
|
| Cash Flow From Continuing Investing Activities |
|
-3.25
|
| Net Other Investing Changes |
|
-3.25
|
| Financing Cash Flow |
|
3.18
|
| Cash Flow From Continuing Financing Activities |
|
3.18
|
| Net Issuance Payments Of Debt |
|
3.18
|
| Issuance Of Debt |
|
3.18
|
| Repayment Of Debt |
|
0.00
|
| Short Term Debt Issuance |
|
3.18
|
| Short Term Debt Payments |
|
0.00
|
| Net Short Term Debt Issuance |
|
3.18
|
| Net Common Stock Issuance |
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.00
|
| Changes In Cash |
|
-0.85
|
| Beginning Cash Position |
|
0.88
|
| End Cash Position |
|
0.03
|
| Free Cash Flow |
|
-0.77
|
| Common Stock Issuance |
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-02 View
- 10-K2026-03-09 View
- 8-K2026-01-29 View
- 8-K2025-12-08 View
- 10-Q2025-11-14 View
- 8-K2025-10-24 View
- 8-K2025-10-03 View
- 8-K2025-09-18 View
- 8-K2025-08-25 View
- 10-Q2025-08-14 View
- 8-K2025-08-05 View
- 8-K2025-07-31 View
- 10-Q2025-05-15 View
- 10-K2025-03-21 View
- 10-Q2024-11-12 View
- 10-Q2024-08-14 View
- 42024-07-25 View
- 8-K2024-07-11 View
- 8-K2024-06-27 View
- 8-K2024-06-20 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|